IL94428A - 2-אמינוטטרלינים 8-מותמרים, תהליך להכנתם ותכשירי הכמילים אותם - Google Patents

2-אמינוטטרלינים 8-מותמרים, תהליך להכנתם ותכשירי הכמילים אותם

Info

Publication number
IL94428A
IL94428A IL9442890A IL9442890A IL94428A IL 94428 A IL94428 A IL 94428A IL 9442890 A IL9442890 A IL 9442890A IL 9442890 A IL9442890 A IL 9442890A IL 94428 A IL94428 A IL 94428A
Authority
IL
Israel
Prior art keywords
compound
alkyl
formula
aryl
treatment
Prior art date
Application number
IL9442890A
Other languages
English (en)
Other versions
IL94428A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL94428A0 publication Critical patent/IL94428A0/xx
Publication of IL94428A publication Critical patent/IL94428A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
IL9442890A 1989-05-26 1990-05-17 2-אמינוטטרלינים 8-מותמרים, תהליך להכנתם ותכשירי הכמילים אותם IL94428A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901889A SE8901889D0 (sv) 1989-05-26 1989-05-26 Novel 8-substituted-2-aminotetralines

Publications (2)

Publication Number Publication Date
IL94428A0 IL94428A0 (en) 1991-03-10
IL94428A true IL94428A (he) 1995-12-31

Family

ID=20376074

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9442890A IL94428A (he) 1989-05-26 1990-05-17 2-אמינוטטרלינים 8-מותמרים, תהליך להכנתם ותכשירי הכמילים אותם

Country Status (41)

Country Link
US (1) US5635537A (he)
EP (1) EP0399982B1 (he)
JP (1) JP2818692B2 (he)
KR (1) KR100193981B1 (he)
CN (1) CN1023399C (he)
AT (1) ATE129696T1 (he)
AU (1) AU644081B2 (he)
CA (1) CA2032498C (he)
CY (1) CY1989A (he)
CZ (1) CZ286038B6 (he)
DD (1) DD298909A5 (he)
DE (1) DE69023274T2 (he)
DK (1) DK0399982T3 (he)
DZ (1) DZ1417A1 (he)
ES (1) ES2078962T3 (he)
FI (1) FI114151B (he)
GR (1) GR3018566T3 (he)
HK (1) HK55697A (he)
HR (1) HRP920622B1 (he)
HU (2) HUT58685A (he)
IE (1) IE75057B1 (he)
IL (1) IL94428A (he)
IS (1) IS1663B (he)
JO (1) JO1617B1 (he)
LT (1) LT3966B (he)
LV (2) LV10243B (he)
MX (1) MX20842A (he)
NO (1) NO176603C (he)
NZ (1) NZ233724A (he)
PH (1) PH31110A (he)
PL (2) PL165166B1 (he)
PT (1) PT94163B (he)
RU (1) RU2093507C1 (he)
SA (1) SA90100274B1 (he)
SE (1) SE8901889D0 (he)
SI (1) SI9011006B (he)
SK (1) SK280731B6 (he)
UA (1) UA40562C2 (he)
WO (1) WO1990014330A1 (he)
YU (1) YU48830B (he)
ZA (1) ZA903801B (he)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2086535C1 (ru) 1989-05-31 1997-08-10 Дзе Апджон Компани Производные 1,2,3,4-тетрагидро-2-нафтиламина
ATE149480T1 (de) * 1990-08-15 1997-03-15 Lilly Co Eli Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
DK0498590T3 (da) * 1991-02-08 1997-05-05 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphthalener
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
US5643910A (en) * 1991-03-28 1997-07-01 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[CD]indoles
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
WO1996015099A1 (en) * 1994-11-09 1996-05-23 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
GB9509156D0 (en) 1995-05-05 1995-06-28 Sandoz Ltd Organic compounds
AU2006335174B2 (en) 2006-01-06 2012-09-06 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
CN117203232A (zh) 2021-03-17 2023-12-08 瑞塞普托斯有限责任公司 用抗il-13抗体治疗特应性皮炎的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4247907A (en) * 1978-11-27 1981-01-27 International Business Machines Corporation Method and apparatus for typing characters and optically readable binary representations thereof on same page
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
EP0168505B1 (en) * 1984-05-22 1989-08-09 Whitby Research Incorporated Substituted 2-aminotetralins and processes for synthesis
DE3660959D1 (de) * 1985-06-26 1988-11-24 Smithkline Beckman Corp Benz-trisubstituted 2-aminotetralins
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
EP0452390B1 (en) * 1989-01-09 1994-10-26 The Upjohn Company Halo substituted aminotetralins
RU2086535C1 (ru) * 1989-05-31 1997-08-10 Дзе Апджон Компани Производные 1,2,3,4-тетрагидро-2-нафтиламина

Also Published As

Publication number Publication date
GR3018566T3 (en) 1996-03-31
IL94428A0 (en) 1991-03-10
PL165166B1 (pl) 1994-11-30
NO910310D0 (no) 1991-01-25
PL285330A1 (en) 1991-11-04
PH31110A (en) 1998-02-23
AU644081B2 (en) 1993-12-02
IE901833L (en) 1990-11-26
NO910310L (no) 1991-01-25
DZ1417A1 (fr) 2004-09-13
IS3580A7 (is) 1990-11-27
KR100193981B1 (ko) 1999-06-15
LTIP1723A (en) 1995-08-25
WO1990014330A1 (en) 1990-11-29
CZ256090A3 (cs) 1999-10-13
HRP920622A2 (en) 1998-06-30
SA90100274B1 (ar) 2005-06-01
KR920701121A (ko) 1992-08-11
DD298909A5 (de) 1992-03-19
NZ233724A (en) 1993-01-27
YU48830B (sh) 2002-03-18
JPH04500362A (ja) 1992-01-23
HK55697A (en) 1997-05-09
HU904810D0 (en) 1991-06-28
CY1989A (en) 1997-09-05
CN1023399C (zh) 1994-01-05
HU211880A9 (en) 1995-12-28
FI910381A0 (fi) 1991-01-25
LT3966B (en) 1996-05-27
AU5818590A (en) 1990-12-18
ZA903801B (en) 1991-01-30
CA2032498C (en) 2002-03-26
JP2818692B2 (ja) 1998-10-30
CZ286038B6 (cs) 1999-12-15
CA2032498A1 (en) 1990-11-27
SI9011006A (en) 1997-12-31
DK0399982T3 (da) 1996-03-04
JO1617B1 (en) 1991-11-27
MX20842A (es) 1993-11-01
LV11736A (lv) 1997-04-20
PL164245B1 (pl) 1994-07-29
RU2093507C1 (ru) 1997-10-20
PT94163A (pt) 1991-01-08
SE8901889D0 (sv) 1989-05-26
NO176603B (no) 1995-01-23
CN1047494A (zh) 1990-12-05
YU100690A (en) 1992-05-28
SK256090A3 (en) 2000-07-11
IE75057B1 (en) 1997-08-27
ES2078962T3 (es) 1996-01-01
IS1663B (is) 1997-07-04
PT94163B (pt) 1996-12-31
HUT58685A (en) 1992-03-30
DE69023274D1 (de) 1995-12-07
EP0399982A1 (en) 1990-11-28
LV10243B (en) 1995-04-20
HRP920622B1 (en) 2000-04-30
ATE129696T1 (de) 1995-11-15
DE69023274T2 (de) 1996-04-11
FI114151B (fi) 2004-08-31
UA40562C2 (uk) 2001-08-15
EP0399982B1 (en) 1995-11-02
LV10243A (lv) 1994-10-20
NO176603C (no) 1995-05-03
LV11736B (en) 1997-10-20
SI9011006B (sl) 1998-12-31
SK280731B6 (sk) 2000-07-11
US5635537A (en) 1997-06-03

Similar Documents

Publication Publication Date Title
US5635537A (en) 8-substituted-2-aminotetralins
US5639778A (en) Indoletetralins having dopaminergic activity
AU641204B2 (en) 3-amino-chromans and thiochromans derivatives
JP2750187B2 (ja) 治療上有効なテトラリン誘導体
EP1096926B1 (en) Methods and compounds for treating depression
KR100302819B1 (ko) 모르폴린유도체및이를포함하는약제
RU2086537C1 (ru) S-энантиомер замещенного 2-аминотетралина, способы его получения и фармацевтическая композиция, обладающая свойством антагониста 5-нт*001*00а-рецептора
EP0470176B1 (en) Substituted 3-amino chromans
JPH02275844A (ja) アリールオキシプロパノールアミノテトラリン類、その製造方法およびそれらを含有する医薬品
EP1171416B1 (en) 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired